A Publication for the Practising Medical Specialist, Industry Executive & Investor

Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States

Medical Device News Magazine delivers the latest updates from the medical device and biotechnology sectors. We take pride in offering high-quality, in-depth content, crafted by a team of experienced professionals. Our goal is to provide a unique perspective on the trends and innovations driving the future of medical technology. By reading our articles, you’re not only gaining exclusive industry insights but also becoming part of a community committed to advancing healthcare through groundbreaking technologies. Explore our content and consider partnering with us for advertising opportunities!

Medical Device Industry News: Latest Developments, Breakthroughs, and Future Outlook

Bio-Rad Launches Annexin V StarBright Conjugates for Apoptosis Detection via Flow Cytometry

“Introduction of Annexin V StarBright Dye conjugates offers customers greater choice and flexibility when detecting apoptosis in both conventional and full spectrum flow cytometry,” said Hilary Mavor, Marketing Director, Life Science Group at Bio-Rad Laboratories. “Bio-Rad has one of the most comprehensive ranges of annexin V conjugates, allowing users to follow best practice and accurately detect apoptosis with minimum spillover with their viability dyes.”

Clinical Trials

Argonne Uncovers Insights About Prostate Cancer Risk and Genetic Ancestry

The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.

AppliedVR and Kernel Flow Announce Clinical Results Evaluating How Brain Changes During Virtual Reality Treatment of Chronic Pain

AppliedVR Co-founder and President Josh Sackman, “We’re committed to developing a significant body of scientific evidence that demonstrates how our RelieVRx program, which is rooted in self-regulation, cognitive behavioral therapy skills and mindfulness, engages the brain and can impact the experience of pain. While we know there can be a strong placebo effect, this feasibility study showed that only the active RelieVRx treatment created changes at a physiological and brain activity level, creating a strong foundation for future research.”

Biotechnology News

Alchemab advances a novel antibody with potential in Parkinson’s disease with support from The Michael J. Fox Foundation

The grant was awarded through MJFF’s Parkinson’s Disease Therapeutics Pipeline Program. The program seeks to advance testing of promising therapeutic developments that address unmet medical needs in people with PD. The program is designed to fund therapeutic development with a clear focus to prevent, stop, or delay disease progression, or to reduce the challenges of daily symptoms.

Mira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled Substance

“We are thrilled with the DEA’s decision, which underscores the potential of MIRA-55 as a groundbreaking therapeutic candidate,” said Erez Aminov, Chairman & CEO of MIRA Pharmaceuticals. “This ruling allows us to focus on MIRA-55’s unique cognitive and anxiety benefits. With access to $90B traditional neurological and $30B cannabis markets, MIRA-55 represents a significant value proposition for our company.  We remain committed to advancing it through the development pipeline for treating these diseases from which so many currently suffer.”

Our Experts – Byline Articles

Read Their Views & Share With a Colleague or Two!

FDA Medical Device Updates

Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding

TympaHealth

TympaHealth Secures $23m in Series A Funding to Revolutionize Ear and Hearing Health Care Delivery

“Our goal is to make ear and hearing healthcare easily accessible to everybody, on a global scale” said Dr Krishan Ramdoo, Founder & CEO of TympaHealth. “Putting the right technology and support into the hands of more healthcare professionals and community providers is the best possible place to start. The Tympa Platform has proven its benefits at every point in the healthcare value chain and with our new funding, we can expand that value to new partners and markets.”

Ciliatech Raises €3.5M in Series A Funding

Ciliatech notes the funds will advance the development of their disruptive glaucoma implant CID and initiate clinical trials in Europe, paving the way for CE mark approval.

Market Reports

Advancements in Imaging

SOTA’s Dental Imaging Software Gets Pearl’s AI Pathology Detection Capabilities

SOTA’s Dental Imaging Software Gets Pearl’s AI Pathology Detection Capabilities

“Together with SOTA, we are pushing the envelope of dental imaging further toward a fully AI-powered dental future,” said Ophir Tanz, Pearl’s founder and CEO. “AI will be a basic utility in dentistry and we see obvious advantages to making that utility an integral feature of the tools that dentists are already using.

Hospitals In the News

Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry

Non-Profit News

Healthcare - Understanding the Business Side of the Industry and Its Implications

Physician Answering Services

24/7 Coverage: How Physician Answering Services Are Changing the Game

Physicians find themselves juggling between patient appointments, emergencies, and the need to maintain a work-life balance. That’s where physician answering services step in, transforming the game by providing 24/7 coverage. Let’s delve into how these services are making a significant impact.

Healthcare Careers

Nurses Corner

Health: A Comprehensive Exploration of Wellness, Nutrition, and Overall Well-Being for a Healthier Life

Articles Designed to Inspire and Guide You Toward Achieving Excellence and Success in All Your Endeavors.